FOR IMMEDIATE RELEASE – American Pharmacogenomics Association Issues Statement on Final FDA Rule for Laboratory Developed Tests (LDTs)
|

FOR IMMEDIATE RELEASE – American Pharmacogenomics Association Issues Statement on Final FDA Rule for Laboratory Developed Tests (LDTs)

The American Pharmacogenomics Association (APGxA) today issued a statement on the Food and Drug Administration’s (FDA) final rule regarding the regulation of laboratory-developed tests (LDTs).

American Pharmacogenomics Association’s Educational Platform Named #1 Best Precision Medicine Blog and Website in 2024

American Pharmacogenomics Association’s Educational Platform Named #1 Best Precision Medicine Blog and Website in 2024

The American Pharmacogenomics Association (APGxA), a pivotal organization dedicated to the advancement of pharmacogenomics, is proud to announce its recognition as the #1 Best Precision Medicine Blog and Website in 2024 by Feedspot.

End of content

End of content